Afya (NASDAQ:AFYA) Stock Rating Upgraded by Wall Street Zen

by · The Markets Daily

Afya (NASDAQ:AFYA – Get Free Report) was upgraded by Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.

Several other equities research analysts have also issued reports on the company. UBS Group dropped their price target on Afya from $19.00 to $18.00 and set a “buy” rating for the company in a research note on Thursday. Weiss Ratings restated a “hold (c)” rating on shares of Afya in a research report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and set a $22.00 price target (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. Two analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $17.88.

Check Out Our Latest Report on Afya

Afya Stock Performance

Afya stock opened at $15.04 on Friday. Afya has a fifty-two week low of $13.47 and a fifty-two week high of $19.90. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 0.98. The stock has a market cap of $1.41 billion, a P/E ratio of 10.82, a price-to-earnings-growth ratio of 0.56 and a beta of 0.53. The firm’s fifty day moving average price is $14.74 and its 200-day moving average price is $15.11.

Institutional Trading of Afya

Institutional investors have recently made changes to their positions in the stock. Susquehanna International Group LLP purchased a new position in shares of Afya in the third quarter worth $419,000. Qube Research & Technologies Ltd bought a new stake in Afya in the 3rd quarter worth $610,000. Doma Perpetual Capital Management LLC increased its position in shares of Afya by 50.6% in the third quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after acquiring an additional 299,419 shares during the period. Lazard Asset Management LLC increased its position in shares of Afya by 167.6% in the third quarter. Lazard Asset Management LLC now owns 49,399 shares of the company’s stock valued at $771,000 after acquiring an additional 30,936 shares during the period. Finally, Squarepoint Ops LLC bought a new position in shares of Afya during the third quarter valued at about $191,000. Hedge funds and other institutional investors own 88.02% of the company’s stock.

About Afya

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

Further Reading